By analyzing multiple cohorts validation, we found that patients with higher levels of TLR3 demonstrated significantly improved survival, increased immune infiltration, and higher TMB, positioning TLR3 as a critical immune modulator in the tumor microenvironment. This evidence concerns the gene TLR3 and neoplasm.